Skip to main content

Stereotactic Body Radiotherapy Viable Alternative for Localized Prostate Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 17, 2024.

By Lori Solomon HealthDay Reporter

THURSDAY, Oct. 17, 2024 -- Stereotactic body radiotherapy (SBRT) is noninferior to conventional or moderately fractionated radiotherapy for localized prostate cancer (PC), according to a study published online Oct. 16 in the New England Journal of Medicine.

Nicholas van As, from the Royal Marsden Hospital in London, and colleagues assessed whether SBRT is noninferior to conventionally or moderately hypofractionated regimens in patients with localized PC. The analysis included patients randomly assigned to SBRT (36.25 Gy in five fractions over one or two weeks) or control radiotherapy (78 Gy in 39 fractions over 7.5 weeks or 62 Gy in 20 fractions over four weeks).

The researchers found that at a median follow-up of 74.0 months, the five-year incidence of freedom from biochemical or clinical failure was 95.8 percent in the SBRT group and 94.6 percent in the control radiotherapy group (unadjusted hazard ratio for biochemical or clinical failure, 0.73; 90 percent confidence interval, 0.48 to 1.12; P = 0.004 for noninferiority). The cumulative incidence of late Radiation Therapy Oncology Group (RTOG) grade ≥2 genitourinary toxic effects at five years was 26.9 percent with SBRT and 18.3 percent with control radiotherapy (P < 0.001). For RTOG grade ≥2 gastrointestinal toxic effects, the cumulative incidence was 10.7 percent and 10.2 percent, respectively (P = 0.94).

“Five-fraction SBRT is a robust and viable alternative to moderately fractionated radiotherapy for prostate cancer, offering equivalent efficacy with enhanced convenience for patients,” the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2024

Read this next

Certain Pesticides Tied to Increased Prostate Cancer Incidence, Mortality

MONDAY, Nov. 4, 2024 -- Some pesticides are associated with increased prostate cancer incidence and mortality, according to a study published online Nov. 4 in Cancer. Simon John...

Protracted Radiation Exposure Linked to Hematologic Cancer Mortality

THURSDAY, Oct. 24, 2024 -- Protracted low-dose exposure to ionizing radiation among radiation-monitored workers is associated with mortality due to some hematologic malignancies...

Higher Heathy Eating Index Score Beneficial in Prostate Cancer

THURSDAY, Oct. 24, 2024 -- Higher adherence to American dietary guideline recommendations may be associated with a lower risk for grade reclassification in men diagnosed with...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.